International Master in Development of Drugs and Health Products

The international master D2HP offers training for future researchers and managers in the pharmaceutical field with a versatile, scientific and technical expertise, and an opening-up to business life or R&D.

M1-M2 Academic Year 2023/2024

Drawing on the expertise of Paris-Saclay’s researchers and professionals, it is intended to provide students with knowledge and skills on the following topics:

(1) Development of biotechnology and innovatives therapies for major diseases; (2) Design and production strategies for drug delivery systems applied to challenging small active pharmaceutical compounds and biomacromolecules; (3) Development of pharmaco-toxicological and analytical methods for evaluation of new therapeutic approaches and prediction of environmental issues.

All core courses include compulsory and elective teaching units that allow students to acquire both professional and transversal skills promoting their employability and personal development.

Through lectures, tutorials, practical works, as well as focused group works, case studies and internships, the students acquire general and specific skills.

Programme overview:

Postgraduate perspectives:

  • PhD training and academic career
  • Drug evaluation in governmental/international agencies
  • Project manager in pharmaceutics, cosmetics, biotechnology, biomedical, regulatory, R&D, quality assurance and quality control
  • Clinical research investigator
  • Research engineer

Course managers:

M1: Prof. Véronique Rosilio, Dr. Eric Morel, and Dr. Sana Tfaili.

M2: Prof. Imad Kansau and Dr. Dorine Bonte, and Dr. Nicolo Tonali

Address: Faculté de Pharmacie – Bâtiment Henri Moissan – 17, avenue des Sciences, 91400 Orsay, France.